PharmaCyte Biotech Inc
0.04 (1.4%)


Draw Mode:

Volume 29,091
Bid Price 2.07
Ask Price 2.95
News -
Day High 2.9199


52 Week Range


Day Low 2.80
Company Name Stock Ticker Symbol Market Type
PharmaCyte Biotech Inc PMCB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 1.4% 2.89 17:00:00
Open Price Low Price High Price Close Price Prev Close
2.9199 2.80 2.9199 2.89 2.85
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
249 29,091 $ 2.82 $ 82,011 - 1.85 - 3.10
Last Trade Time Type Quantity Stock Price Currency
17:58:22 1 $ 2.75 USD

PharmaCyte Biotech Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 50.41M 17.44M 20.67M $ - $ - -0.80 9.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 250.00k 3.40%

more financials information »

PharmaCyte Biotech News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No PMCB Message Board. Create One! See More Posts on PMCB Message Board See More Message Board Posts

Historical PMCB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.842.992.782.8941,8500.051.76%
1 Month2.933.022.782.9336,887-0.04-1.37%
3 Months2.893.052.782.9654,7300.000.0%
6 Months2.493.102.342.8583,3750.4016.06%
1 Year2.373.101.852.33195,6310.5221.94%
3 Years3.089.981.796.111,271,176-0.19-6.17%
5 Years3.089.981.796.111,271,176-0.19-6.17%

PharmaCyte Biotech Description

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. It is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.